Fausto Avanzini
Overview
Explore the profile of Fausto Avanzini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Avanzini F, Amodeo R, Colombo L, Corticelli A, Saltafossi D, Chiappa L, et al.
Assist Inferm Ric
. 2024 Sep;
43(3):118-129.
PMID: 39301731
Introduction: Guidelines suggest careful monitoring of patients after acute heart failure (AHF) or acute myocardial infarction (AMI). Objective: To describe the implementation of the 'accompanied discharge' (DIMACC) pathway for patients...
2.
Baviera M, Genovese S, Lepore V, Colacioppo P, Robusto F, Tettamanti M, et al.
Diabetes Obes Metab
. 2021 Feb;
23(7):1484-1495.
PMID: 33606897
Aim: To examine the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with other antihyperglycaemic agents (AHAs) in large and unselected populations of...
3.
Moreira J, Figueroa M, Anselmi M, Prandi R, Montano C, Bell D, et al.
Glob Heart
. 2019 Nov;
14(4):373-378.
PMID: 31727267
Background: In contrast with the abundance of global epidemiological descriptive data on cardiovascular diseases and their risk factors, information on the outcomes of real populations prospectively followed up in their...
4.
Cappellini F, Falbo R, Saltafossi D, Avanzini F, Signorini S, Fania C, et al.
Clin Chim Acta
. 2019 Mar;
495:1-7.
PMID: 30910596
Introduction: Chest pain and its clinical manifestations are the most common reasons for presentation to the emergency department (ED). Given that the prevalence of chest pain due to acute myocardial...
5.
Baviera M, Bertele V, Avanzini F, Vannini T, Tettamanti M, Fortino I, et al.
Eur J Prev Cardiol
. 2018 Apr;
25(16):1735-1743.
PMID: 29664343
Background The aim of our study was to evaluate whether treatments for peripheral artery disease changed in two different cohorts identified in 2002 and 2008, and whether this had an...
6.
Marzona I, Avanzini F, Tettamanti M, Vannini T, Fortino I, Bortolotti A, et al.
Acta Diabetol
. 2018 Jan;
55(4):355-362.
PMID: 29357034
Aims: To describe the prevalence and management of diabetes among immigrants according to ethnic group and duration of stay, compared to Italian citizens. Methods: Diabetic immigrant and Italian residents aged...
7.
Marzona I, Avanzini F, Lucisano G, Tettamanti M, Baviera M, Nicolucci A, et al.
Acta Diabetol
. 2016 Oct;
54(2):123-131.
PMID: 27718051
Aims: To verify whether it is possible, in people with diabetes mellitus (DM) considered at very high cardiovascular (CV) risk, stratify this risk better and identify significant modifiable risk factor...
8.
Avanzini F, Marzona I, Baviera M, Barlera S, Milani V, Caimi V, et al.
Eur J Prev Cardiol
. 2015 Nov;
23(9):947-55.
PMID: 26525065
Background: Although high cardiovascular risk patients should be the main target of preventive strategies, modifiable risk factors are often inadequately controlled. Aim: To assess feasibility and results of a comprehensive...
9.
Marelli G, Avanzini F, Iacuitti G, Planca E, Frigerio I, Busi G, et al.
J Diabetes Res
. 2015 May;
2015:173956.
PMID: 25961051
Background: Hypoglycemia due to inadequate carbohydrate intake is a frequent complication of insulin treatment of diabetic in-patients. Objective. To assess the effectiveness of a nurse-managed protocol to prevent hypoglycemia during...
10.
Avanzini F, Marelli G, Saltafossi D, Longhi C, Carbone S, Carlino L, et al.
Eur Heart J Acute Cardiovasc Care
. 2015 Mar;
5(2):117-24.
PMID: 25735300
Objectives: To assess the effectiveness, safety and feasibility of the revised, simplified nurse-managed version of our insulin infusion protocol, adapted to the new recommended glycaemic target of 140 to 180...